Identification of Electrophysiological Changes in Alzheimer's Disease: A Microarray Based Transcriptomics and Molecular Pathway Analysis Study

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|16|9|1027-1038

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.16, Iss.9, 2018-01, pp. : 1027-1038

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transcriptomics Study of Neurodegenerative Disease: Emphasis on Synaptic Dysfunction Mechanism in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1202-1212

Bentham Science Publishers

Access to resources Recommend Favorite

Gene identification in Alzheimer’s disease

By Saunders Ann M  

Pharmacogenomics, Vol. 2, Iss. 3, 2001-08 ,pp. : 239-249

Future Medicine

Access to resources Recommend Favorite

Underlying neurotransmitter changes in Alzheimer's disease

By Francis P.T.   Alder J.T.   C. P.L.-H.C.   Chessell I.P.   Clarke N.A.   Dijk S.N.   Procter A.W.   Webster M.-T.   Bowen D.M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 203-204

Elsevier

Access to resources Recommend Favorite

Molecular and Biochemical Features in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4389-4408

Bentham Science Publishers

Access to resources Recommend Favorite

Disease altering therapeutic strategies based on the molecular dissection of the amyloid lesions in Alzheimer's disease

By Beyreuther K.   Masters C.L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 205-206

Elsevier

Access to resources Recommend Favorite